From ex vivo to in vivo chimeric antigen T cells manufacturing: new horizons for CAR T-cell based therapy

p53-regulated non-apoptotic cell death pathways and their relevance in cancer and other diseases

Mutation of TP53 Confers Ferroptosis Resistance in Lung Cancer Through the FOXM1/MEF2C Axis

PSCA and MUC1 in non-small-cell lung cancer as targets of chimeric antigen receptor T cells